SI2340506T1 - Biomarkerji za pljučni rak in njihove uporabe - Google Patents

Biomarkerji za pljučni rak in njihove uporabe

Info

Publication number
SI2340506T1
SI2340506T1 SI200931363T SI200931363T SI2340506T1 SI 2340506 T1 SI2340506 T1 SI 2340506T1 SI 200931363 T SI200931363 T SI 200931363T SI 200931363 T SI200931363 T SI 200931363T SI 2340506 T1 SI2340506 T1 SI 2340506T1
Authority
SI
Slovenia
Prior art keywords
lung cancer
cancer biomarkers
biomarkers
lung
cancer
Prior art date
Application number
SI200931363T
Other languages
English (en)
Inventor
Larry Gold
Marty Stanton
Edward N. Brody
Rachel M. Ostroff
Dominic Zichi
Alex A. E. Stewart
Original Assignee
Somalogic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic, Inc. filed Critical Somalogic, Inc.
Publication of SI2340506T1 publication Critical patent/SI2340506T1/sl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10Complex mathematical operations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Algebra (AREA)
  • Software Systems (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Analysis (AREA)
SI200931363T 2008-09-09 2009-09-09 Biomarkerji za pljučni rak in njihove uporabe SI2340506T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9559308P 2008-09-09 2008-09-09
US15283709P 2009-02-16 2009-02-16
EP09813557.7A EP2340506B1 (en) 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof
PCT/US2009/056399 WO2010030697A1 (en) 2008-09-09 2009-09-09 Lung cancer biomarkers and uses thereof

Publications (1)

Publication Number Publication Date
SI2340506T1 true SI2340506T1 (sl) 2016-02-29

Family

ID=42005456

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200931363T SI2340506T1 (sl) 2008-09-09 2009-09-09 Biomarkerji za pljučni rak in njihove uporabe

Country Status (14)

Country Link
EP (1) EP2340506B1 (sl)
JP (1) JP5701212B2 (sl)
KR (1) KR101658347B1 (sl)
CN (2) CN104198709A (sl)
AU (2) AU2009291811B2 (sl)
CA (3) CA3011730C (sl)
DK (1) DK2340506T3 (sl)
ES (1) ES2559758T3 (sl)
GB (1) GB2478441B (sl)
HK (2) HK1153834A1 (sl)
HR (1) HRP20160127T1 (sl)
MX (1) MX2011002322A (sl)
SI (1) SI2340506T1 (sl)
WO (1) WO2010030697A1 (sl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
EP2857522A3 (en) 2009-03-12 2015-10-14 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
EP2591357A4 (en) * 2010-07-09 2014-01-01 Somalogic Inc BIOMARKER FOR LUNG CANCER AND USE
CA2804857C (en) 2010-08-13 2021-07-06 Somalogic, Inc. Pancreatic cancer biomarkers and uses thereof
RU2612017C2 (ru) * 2011-04-07 2017-03-01 Де Скриппс Рисерч Инститьют Высокопроизводительный скрининг соединений, модулирующих экспрессию клеточных макромолекул
CN110444287B (zh) 2011-04-29 2024-02-06 癌症预防和治疗有限公司 使用分类系统及其试剂盒识别和诊断肺部疾病的方法
CN103890586B (zh) * 2011-10-24 2016-06-29 私募蛋白质体公司 肺癌生物标记及其用途
US9201044B2 (en) * 2011-12-21 2015-12-01 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
WO2013121374A2 (en) * 2012-02-17 2013-08-22 Koninklijke Philips N.V. Acute lung injury (ali)/acute respiratory distress syndrome (ards) assessment and monitoring
WO2014074682A1 (en) 2012-11-07 2014-05-15 Somalogic, Inc. Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof
BR112016010322A2 (pt) 2013-11-07 2017-08-08 Medial Res Ltd Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão
KR102078310B1 (ko) * 2015-09-11 2020-02-19 주식회사 압타머사이언스 비소세포성 폐암 진단용 단백질 바이오마커 패널 및 이를 이용한 비소세포성 폐암 진단 방법
FR3050269B1 (fr) * 2016-04-15 2018-05-11 Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) Procede de selection et de recuperation de produits et systeme associe
CN105823665A (zh) * 2016-05-13 2016-08-03 北京九州柏林生物科技有限公司 生物组织样本制备套液
SG11201810914VA (en) 2016-06-21 2019-01-30 Wistar Inst Compositions and methods for diagnosing lung cancers using gene expression profiles
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
WO2018187496A2 (en) 2017-04-04 2018-10-11 Lung Cancer Proteomics, Llc Plasma based protein profiling for early stage lung cancer prognosis
KR102633621B1 (ko) 2017-09-01 2024-02-05 벤 바이오사이언시스 코포레이션 진단 및 치료 모니터링용 바이오마커로서의 당펩티드의 식별 및 용도
CN111630602A (zh) * 2017-11-22 2020-09-04 磨石肿瘤生物技术公司 减少新抗原的接合表位呈递
BR112020026129B1 (pt) * 2018-06-22 2023-10-10 Somalogic Operating Co., Inc Métodos para melhorar o desempenho de ensaios proteômicos multiplex
EP3987292A4 (en) * 2019-06-21 2023-10-11 National University of Singapore METHODS OF DETERMINING THE LIKELIHOOD OF LUNG CANCER
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
CN111047609B (zh) * 2020-03-13 2020-07-24 北京深睿博联科技有限责任公司 肺炎病灶分割方法和装置
CN116381073A (zh) * 2020-10-10 2023-07-04 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 生物标志物在制备肺癌检测试剂中的用途和方法
CN112557514B (zh) * 2020-12-22 2021-09-21 中国海洋大学 手持式海底沉积物样品剖面声学全自动测量装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US20030199685A1 (en) * 2001-03-12 2003-10-23 Monogen, Inc. Cell-based detection and differentiation of disease states
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
JP2005527180A (ja) * 2001-04-18 2005-09-15 プロテイン デザイン ラブス, インコーポレイテッド 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法
EP1739185A1 (en) * 2002-12-18 2007-01-03 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
CN1225477C (zh) * 2003-03-28 2005-11-02 上海市疾病预防控制中心 肺癌早期血清特异蛋白及其应用
CN1455257A (zh) * 2003-05-23 2003-11-12 北京师范大学 一种利用表面修饰蛋白芯片进行肺癌诊断方法
TW200600785A (en) * 2004-03-23 2006-01-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancer
JP2005304497A (ja) * 2004-03-25 2005-11-04 Joji Inasawa 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法
ES2367311T3 (es) * 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
CA2564396A1 (en) * 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
MX2007001357A (es) * 2004-08-02 2009-08-07 Childrens Medical Center Biomarcadores de plaquetas para cancer.
CN1873417A (zh) * 2005-06-02 2006-12-06 中国医学科学院肿瘤医院肿瘤研究所 一种用于诊断肺癌的蛋白质芯片
JP5160447B2 (ja) * 2005-12-22 2013-03-13 アボット・ラボラトリーズ 肺がんへの傾向についてのスクリーニングのための方法およびマーカー組合せ
WO2007109571A2 (en) * 2006-03-17 2007-09-27 Prometheus Laboratories, Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
EP2074224A4 (en) * 2006-10-17 2010-07-21 Synergenz Bioscience Ltd METHOD AND COMPOSITIONS FOR ASSESSING LUNG FUNCTION AND LUNG RIDING
WO2008097908A2 (en) * 2007-02-05 2008-08-14 Dana-Farber Cancer Institute, Inc. Methods of diagnosing and prognosing lung cancer
KR100846354B1 (ko) * 2007-03-21 2008-07-15 (주) 프로탄바이오 혈청 당단백질부터 분리한 폐암 진단용 마커
CA2684945A1 (en) * 2007-05-18 2008-11-27 University Of Southern California Germline polymorphisms in the angiogenic pathway predict tumor recurrence in cancer therapy
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
WO2010003772A1 (en) * 2008-06-16 2010-01-14 Siemens Medical Solutions Diagnostics Gmbh Method for predicting adverse response to erythropoietin in breast cancer treatment
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
AU2011215789A1 (en) * 2010-02-10 2012-08-30 The Regents Of The University Of California Salivary biomarkers for lung cancer detection

Also Published As

Publication number Publication date
AU2015249113B2 (en) 2017-09-07
AU2009291811A1 (en) 2010-03-18
EP2340506A4 (en) 2012-02-15
JP2012502281A (ja) 2012-01-26
GB201106053D0 (en) 2011-05-25
CA3152591C (en) 2023-08-29
HK1153834A1 (en) 2012-04-05
KR20110063753A (ko) 2011-06-14
EP2340506B1 (en) 2015-11-11
CN102209968B (zh) 2016-05-04
MX2011002322A (es) 2011-05-10
AU2015249113A1 (en) 2015-11-12
GB2478441A (en) 2011-09-07
CN104198709A (zh) 2014-12-10
AU2009291811B2 (en) 2015-10-29
EP2340506A1 (en) 2011-07-06
CA2734535C (en) 2018-08-28
CA2734535A1 (en) 2010-03-18
CN102209968A (zh) 2011-10-05
GB2478441B (en) 2013-03-27
HK1204062A1 (en) 2015-11-06
CA3152591A1 (en) 2010-03-18
JP5701212B2 (ja) 2015-04-15
WO2010030697A1 (en) 2010-03-18
HRP20160127T1 (hr) 2016-03-11
ES2559758T3 (es) 2016-02-15
CA3011730A1 (en) 2010-03-18
DK2340506T3 (en) 2016-02-08
CA3011730C (en) 2022-05-17
KR101658347B1 (ko) 2016-09-21

Similar Documents

Publication Publication Date Title
HK1204062A1 (en) Lung cancer biomarkers and uses thereof
IL269454B (en) Qualitative losses and their uses
IL223295A0 (en) Lung cancer biomarkers and uses thereof
EP2227556A4 (en) LUNG CANCER MARKERS AND THEIR USES
GB0719792D0 (en) Cancer biomarkers
EP2443259A4 (en) BIOMARKERS FOR AUTISM AND USES THEREOF
IL202727A0 (en) Covalent diabodies and uses thereof
EP2250287A4 (en) PROOF AND FORECAST OF LUNG CANCER
EP2265642A4 (en) BIOMARKERS
EP2457092A4 (en) CANCER BIOMARKERS AND THEIR USE
EP2263086A4 (en) BIOMARKERS
GB0616230D0 (en) Biomarkers and uses thereof
EP2350917A4 (en) BIOMARKERS OF OVARIAN CANCER AND USES THEREOF
GB0818660D0 (en) Biomarkers
GB0807214D0 (en) Biomarkers
EP2265641A4 (en) BIOMARKERS
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers
GB0720334D0 (en) Cancer biomarker
AU2009900954A0 (en) Cancer Biomarkers and Uses Therefor
GB0809105D0 (en) Biomarkers
GB0805081D0 (en) Biomarkers
GB0805084D0 (en) Biomarkers